Michael Wilson, MD
Neurology · San Francisco, CANPI 1134324791
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,240 of the $5,240 with a category attached, or 100.0%. 3 manufacturers reported payments, led by Vertex at 45.8% of the total.
Across 3 payments — averaging $1746.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Genentech, Inc.$1K
Across 4 payments — averaging $63,228 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$253K
What the payments were for
- Consulting fees$5,240100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 1 | $2,400 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,840 |
| Genentech, Inc. | 1 | $1,000 |
How this compares
$5,240 in reported general payments places this provider in the 65th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VumerityDiroximel Fumarate | 11 | $84,900 |
| Baclofen | 48 | $2,719 |
| Dimethyl Fumarate | 11 | $2,403 |
| Methylphenidate ErMethylphenidate Hcl | 12 | $710 |
Paid to pharmacies, not to this prescriber.
Other neurology in San Francisco
- S Claiborne JohnstonSan Francisco$576K
- Armen MoughamianSan Francisco$554K
- Scott ZamvilSan Francisco$447K
- Bruce CreeSan Francisco$412K
- Kenneth LaxerSan Francisco$379K
- Jonathan KatzSan Francisco$294K
- Nada HindiyehSan Francisco$268K
- Douglas GoodinSan Francisco$227K
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.